Citation 10685

KAGUERA,T: MATSUDA,H: MORIKAWA,T: TOGUCHIDA,I: HARIMA,S: ODA,M: YOSHIKAWA,M:. (2001). INHIBITORS FROM RHUBARA ON LIPOPOLYSACCHARIDE-INDUCED NITRIC OXIDE PRODUCTION IN MACROPHAGES: STRUCTURAL REQUIREMENTS OF STILBENES FOR THE ACTIVITY.. 9(7)

Citation Details

Title	INHIBITORS FROM RHUBARA ON LIPOPOLYSACCHARIDE-INDUCED NITRIC OXIDE PRODUCTION IN MACROPHAGES: STRUCTURAL REQUIREMENTS OF STILBENES FOR THE ACTIVITY.
Authors	KAGUERA,T: MATSUDA,H: MORIKAWA,T: TOGUCHIDA,I: HARIMA,S: ODA,M: YOSHIKAWA,M:
Year	2001
Volume	9
Issue	7

Summary

Year: 2001

Journal: Unknown

Organisms and Their Experiments (2)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRYSOPHANIC ACID	INACTIVE
2	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EMODIN	INACTIVE
3	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHYSCION	INACTIVE
4	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RHEIN	ACTIVE
5	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ALOE EMODIN	INACTIVE
6	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GALLIC ACID	ACTIVE
7	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SENNOSIDE A	INACTIVE
8	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SENNOSIDE B	INACTIVE

Rheum undulatum (POLYGONACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
2	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
3	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
4	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	RHAPONTICIN	None
5	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RHAPONTICIN	INACTIVE
6	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	PICEATANNOL-3'-O-BETA-D-GLUCOSIDE	None
7	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PICEATANNOL-3'-O-BETA-D-GLUCOSIDE	INACTIVE
8	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	RHAPONTICIN,DEOXY:	None
9	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RHAPONTICIN,DEOXY:	INACTIVE
10	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	RHAPONTIN,ISO:	None
11	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RHAPONTIN,ISO:	INACTIVE
12	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	RHAPONTIGENIN	None
13	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RHAPONTIGENIN	ACTIVE
14	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	PICEATANNOL	None
15	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PICEATANNOL	ACTIVE
16	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	RHAPONTIGENIN,DEOXY:	None
17	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RHAPONTIGENIN,DEOXY:	INACTIVE
18	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	RESVERATROL	None
19	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESVERATROL	ACTIVE
20	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	RHAPONTICIN-2''-O-GALLATE	None
21	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RHAPONTICIN-2''-O-GALLATE	ACTIVE
22	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	RHAPONTICIN-6''-O-GALLATE	None
23	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RHAPONTICIN-6''-O-GALLATE	ACTIVE
24	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	ALOE EMODIN-1-O-BETA-D-GLUCOSIDE	None
25	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ALOE EMODIN-1-O-BETA-D-GLUCOSIDE	INACTIVE
26	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CHRYSOPHANIC ACID 1-O-BETA-D-GLUCOSIDE	None
27	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRYSOPHANIC ACID 1-O-BETA-D-GLUCOSIDE	INACTIVE
28	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CHRYSOPHANIC ACID 8-O-BETA-D-GLUCOSIDE	None
29	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRYSOPHANIC ACID 8-O-BETA-D-GLUCOSIDE	INACTIVE
30	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CHRYSOPHANIC ACID 8-O-BETA-D-(6'-GALLOYL)-GLUCOSIDE	None
31	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRYSOPHANIC ACID 8-O-BETA-D-(6'-GALLOYL)-GLUCOSIDE	INACTIVE
32	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	TORACHRYSONE-8-O-BETA-D-GLUCOSIDE	None
33	NITRIC OXIDE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TORACHRYSONE-8-O-BETA-D-GLUCOSIDE	ACTIVE